Checkpoint Therapeutics, Inc. - Common Stock (NQ: CKPT )

3.495 -0.025 (-0.71%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist

Price and Volume

Volume	988,984
Open	3.500
Bid (Size)	3.490 (2)
Ask (Size)	3.530 (3)
Prev. Close	3.520
Today's Range	3.361 - 3.600
52wk Range	1.380 - 4.500
Shares Outstanding	45,095,500
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

December 20, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NASDAQ:PSNL),(NASDAQ:TEM),(NASDAQ:CKPT) EQNX::TICKER_END

Via FinancialNewsMedia

FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection

December 16, 2024

Checkpoint Therapeutics' Unloxcyt wins FDA approval for advanced cSCC, marking the company's entry into the U.S. market, valued over $1 billion annually.

Via Benzinga

Performance

YTD	+59.59%	+59.59%
1 Month	-18.34%	-18.34%
3 Month	+55.33%	+55.33%
6 Month	+62.56%	+62.56%
1 Year	+54.65%	+54.65%

More News

US Stocks To Open Higher Ahead Of Fed's Decision This Week: Analyst Says 'Santa Comes Later In December'

December 16, 2024

Via Benzinga

CKPT Stock Earnings: Checkpoint Therapeutics Beats EPS, Beats Revenue for Q2 2024

August 12, 2024

Via InvestorPlace

CHECKPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating Checkpoint Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

June 05, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

CKPT DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT

June 04, 2024

Via NewMediaWire

CKPT DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT

June 04, 2024

Via TheNewswire.com

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm

June 04, 2024

From Schall Law

Via GlobeNewswire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Checkpoint Therapeutics, Inc. (CKPT)

June 03, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

CKPT FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT

June 03, 2024

Via NewMediaWire

CKPT FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT

June 03, 2024

Via TheNewswire.com

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint

June 03, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

CHECKPOINT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Checkpoint Therapeutics, Inc. and Encourages Investors to Contact the Firm

May 31, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A LEADING LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action – CKPT

May 30, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint

May 30, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm

May 28, 2024

From Schall Law

Via GlobeNewswire

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT

May 26, 2024

Via NewMediaWire

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action - CKPT

May 26, 2024

Via TheNewswire.com

CKPT SHAREHOLDER ALERT: TOP RANKED ROSEN LAW FIRM Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important June 4 Deadline in Securities Class Action – CKPT

May 23, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

SHAREHOLDER ALERT Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint

May 22, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

June 4th Lead Plaintiff Deadline Approaching in Class Action Against Checkpoint Therapeutics, Inc. – Contact Robbins LLP Today

May 21, 2024

From Robbins LLP

Via GlobeNewswire

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm

May 21, 2024

From Schall Law

Via GlobeNewswire

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT

May 20, 2024

Via NewMediaWire

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT

May 20, 2024

Via TheNewswire.com

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CKPT

May 17, 2024

Via NewMediaWire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.